Biofrontera Inc. BFRI 深 沪
交易中 08-21 10:36:41 美东时间
1.4899
+0.010
+0.67%
华盛通- 最 高1.52
- 今 开1.48
- 成交量 10.10万股
- 最 低 1.47
- 昨 收 1.48
- 总市值 2212.85万
- 52周最高 1.52
- 市盈率 静 --
- 换手率 0.68%
- 52周最低 0.5547
- 委 比 -11.29%
- 总股本 1485.24万
- 历史最高 292.60
- 量 比 0.98
- 振 幅 3.38%
- 历史最低 0.536
- 每 手 1
- 风险率 0.14%
个股概要
财务分析
公司资料
相关新闻
分红派息
- 分时图
- 日k
- 周k
- 月k
相关新闻
更多Biofrontera Q2 EPS $(0.05) Misses $(0.04) Estimate, Sales $12.003M Beat $10.500M Estimate
Biofrontera (NASDAQ:BFRI) reported quarterly losses of $(0.05) per share which missed the analyst consensus estimate of $(0.04) by 25 percent. This is a 91.23 percent increase over losses of $(0.57) per share from the same period last year. The company reported quarterly sales of $12.003 million whi...
08-13 20:54
Biofrontera Inc. to Report Second Quarter 2026 Financial Results on August 13, 2026
Biofrontera Inc. (NASDAQ: BFRI) announced it will report Q2 2026 financial results before the market opens on August 13, 2026. A conference call and webcast will be held at 10:00 a.m. ET the same day to discuss the results. U.S./Canada participants can dial 1-877-877-1275, while international participants can dial 1-412-858-5202. The webcast will be available at https://event.choruscall.com/mediaframe/webcast.html?webcastid=a2Bp6alz beginning 20 ...
08-05 20:15
美股大行评级 | 最高1100美元，花旗、瑞穗、 Melius Research齐上调美光目标价；X-Energy获大小摩等多家机构首予“买入”评级
今日重点评级关注：TD Cowen：维持Strategy"买入"评级，目标价从395美元升至400美元；摩根士丹利：维持Cipher Digital"超配"评级，目标价从40.5美元升至42.5美元
05-20 11:55
Benchmark Downgrades Biofrontera to Speculative Buy, Maintains Price Target to $3
Benchmark analyst Bruce D. Jackson downgrades Biofrontera (NASDAQ:BFRI) from Buy to Speculative Buy and maintains the price target from $3 to $3.
05-19 20:41
美股夜盘 | DirectBooking Technology Co., Ltd. Class A涨38.62%，WEX Inc.涨19.54%
P3 Health Partners Inc. Class A涨-17.63%；Artelo Biosciences Inc涨-14.67%；Lantern Pharma, Inc.涨-12.42%
05-18 08:05
Biofrontera目标2026年实现现金流盈亏平衡 毛利率剑指80%-85%
一季度业绩：营收增长17% 毛利率显著提升至80% Biofrontera近日公布2026年第一季度财报。数据显示，公司一季度产品营收达1010万美元...
05-15 03:09
Transcript: Biofrontera Q1 2026 Earnings Conference Call
On Thursday, Biofrontera (NASDAQ:BFRI) discussed first-quarter financial result...
05-14 23:39
Biofrontera Q1 EPS $(0.41) Misses $(0.12) Estimate, Sales $10.084M Miss $10.250M Estimate
Biofrontera (NASDAQ:BFRI) reported quarterly losses of $(0.41) per share which missed the analyst consensus estimate of $(0.12) by 272.73 percent. This is a 12.77 percent increase over losses of $(0.47) per share from
05-14 20:08
Earnings Scheduled For May 14, 2026
Companies Reporting Before The Bell • Urban One (NASDAQ:UONEK) is expected to r...
05-14 19:11
